Skip to content
Events
ASHG Annual Meeting

Details

Join us in Denver, Colorado, from November 5 – 9, to learn about our latest advancements in sequencing, informatics, array and library prep solutions. From advancements on our NovaSeq X and NextSeq 1000/2000 workflows to microarray systems and informatic solutions, Illumina offers the tools that fit the complex needs of researchers across the genomic spectrum. From scalable single -omic to multi-omic solutions, come learn how Illumina can partner with you in advancing your genetics and genomic research.

Visit Illumina booth 503 at ASHG 2024, and attend our industry education session and co-labs to hear more about our products, workflow solutions, and partnerships.

Industry Education sessions

Wednesday, Nov. 6 at 12 PM–1 PM (MT)
Rooms 109/111/113

Steve Barnard, PhD

Illumina Innovation Roadmap
Steve Barnard, PhD
Chief Technology Officer
Illumina

Join us to hear from Steve Barnard about the latest Illumina innovations from library prep, sequencing, and analysis and learn how we are enabling transformative applications using multiomics. Niall Lennon, PhD from the Broad Institute of MIT will join Steve to provide insights into new Illumina technology.

M-AMR-01576
Date & Time
5 Nov. 2024 – 9 Nov. 2024
Location
Colorado Convention Center
Illumina Booth 503
Denver, Colorado
Topic
Instruments, Software & informatics
Visit Website

Related Events

Nov 6
Your Vision Our Workflow - Illumina’s solution for clinical research in rare and inherited disease
Nov 6, 2024
In this webinar you will hear from two speakers: Anthony Beckhouse on the benefits and flexibility of the NextSeq 1K/2k, and Michael Fietz on the accuracy and speed of our secondary analysis solution DRAGEN, as well as how our tertiary analysis solution Emedgene can help address bottlenecks of analysis and reporting for rare and inherited disease research. With Illumina’s exome or genome sequencing as a backbone, and the ability to do virtual panels with our tertiary solution - Emedgene. Laboratories can now create comprehensive assays to enable the latest genomic discoveries.
View Event
Nov 6
Your Vision Our Workflow - Illumina’s solution for clinical research in rare and inherited disease
Nov 6, 2024
In this webinar you will hear from two speakers: Anthony Beckhouse on the benefits and flexibility of the NextSeq 1K/2k, and Michael Fietz on the accuracy and speed of our secondary analysis solution DRAGEN, as well as how our tertiary analysis solution Emedgene can help address bottlenecks of analysis and reporting for rare and inherited disease research. With Illumina’s exome or genome sequencing as a backbone, and the ability to do virtual panels with our tertiary solution - Emedgene. Laboratories can now create comprehensive assays to enable the latest genomic discoveries.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.